Sunshine Biopharma Inc. Finite-lived Intangible Assets Acquired
Sunshine Biopharma Inc. (SBFM) reported Finite-lived Intangible Assets Acquired of $32.68 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Goodwill and Other
us-gaap:FinitelivedIntangibleAssetsAcquired1 · last filed 2026-08-13
- Sunshine Biopharma Inc. finite-lived intangible assets acquired for fiscal 2022 was $659.57K.
| Period end | Finite-lived Intangible Assets Acquired 6 month | Finite-lived Intangible Assets Acquired 12 month |
|---|---|---|
| 2026-06-30 | $32.68K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $774.36K 10-Q · filed 2026-08-13 | |
| 2022-12-31 | $659.57K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |